caffeic acid phenethyl ester has been researched along with berberine in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (berberine) | Trials (berberine) | Recent Studies (post-2010) (berberine) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 4,106 | 102 | 2,791 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | berberine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.7827 | |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 6.97 | |
| Cholinesterase | Homo sapiens (human) | 1.09 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.4 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 4.99 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 6.71 | |
| Cholinesterase | Equus caballus (horse) | 9.4 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.9747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Feng, F; Guo, Q; He, S; Liu, W; Liu, Y; Sun, H; Zhao, L | 1 |
1 review(s) available for caffeic acid phenethyl ester and berberine
| Article | Year |
|---|---|
Overview of AKR1C3: Inhibitor Achievements and Disease Insights.
Topics: Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Binding Sites; Cell Proliferation; Clinical Trials as Topic; Drug Development; Drug Resistance, Neoplasm; Humans; Models, Molecular; Molecular Structure; Neoplasms; Treatment Outcome | 2020 |